The selected GSC superenhancers were enriched for transcriptional motifs, including NR4A2, SMAD3, and ETV4, which have been previously reported to promote glioblastoma malignancy (31–33) (Figure 1D). The gene discussed is ETV4; the disease is glioblastoma.